4- (4- (4- chloro- phenyl)thiazol- 2- ylamino)phenol
orally bioavailable sphingosine kinase inhibitor
Also Known As:
2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole; 4-((4-(4-chloro-phenyl)thiazol-2-yl)amino)phenol; 4-(4-(4-chlorophenyl)thiazol-2-ylamino)phenol; SKI-11 compound
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Alossaimi, Manal:
1 article
(04/2013)
|
2. | Berdyshev, Evgeny:
1 article
(04/2013)
|
3. | Bittman, Robert:
1 article
(04/2013)
|
4. | Chan, Edmond:
1 article
(04/2013)
|
5. | Gorshkova, Irina:
1 article
(04/2013)
|
6. | Pyne, Nigel J:
1 article
(04/2013)
|
7. | Pyne, Susan:
1 article
(04/2013)
|
8. | Tonelli, Francesca:
1 article
(04/2013)
|
9. | Watson, David G:
1 article
(04/2013)
|
10. | Williamson, Leon:
1 article
(04/2013)
|
Related Diseases
Related Drugs and Biologics